BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28622854)

  • 1. Linear DNA vaccine prepared by large-scale PCR provides protective immunity against H1N1 influenza virus infection in mice.
    Wang F; Chen Q; Li S; Zhang C; Li S; Liu M; Mei K; Li C; Ma L; Yu X
    Vet Microbiol; 2017 Jun; 205():124-130. PubMed ID: 28622854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of seasonal pandemic influenza hemagglutinin DNA vaccines delivered by electroporation against a seasonal H1N1 virus challenge in mice.
    Tan L; Lu H; Zhang D; Wang K; Tian M; Liu C; Liu Y; Hu B; Jin N
    Sci China Life Sci; 2011 Apr; 54(4):293-9. PubMed ID: 21416231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immune protective effectiveness of seasonal influenza spilt vaccine against homologous and heterogonous subtypes of influenza virus in mice].
    Huang BY; Wang XP; Wang WL; Hu W; Gao Q; Tan WJ; Ruan L
    Bing Du Xue Bao; 2011 May; 27(3):265-73. PubMed ID: 21774253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with polymerase chain reaction-generated linear expression cassettes protects mice against lethal influenza A challenge.
    Vilalta A; Jimenez G; Rusalov D; Planchon R; Lalor P; Carner K; Chaplin JA; Komai M; Manthorpe M; Kaslow DC; Rolland A
    Hum Gene Ther; 2007 Aug; 18(8):763-71. PubMed ID: 17705698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with a low dose of hemagglutinin-encoding plasmid protects against 2009 H1N1 pandemic influenza virus in mice.
    Fang J; Chen Z; Liu X; Li H; Wang J; Shen X; Chen W; Liu Y; Wang Y; Zhao P; Qi Z
    J Virol Methods; 2011 May; 173(2):314-9. PubMed ID: 21392537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of antibody induction and protection against influenza virus infection by DNA immunization with HA, HAe, and HA1 in mice.
    Chen J; Liu Q; Chen Q; Xiong C; Yao Y; Wang H; Wang H; Chen Z
    Arch Virol; 2014 Apr; 159(4):689-700. PubMed ID: 24132721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune effects against influenza A virus and a novel DNA vaccine with co-expression of haemagglutinin- and neuraminidase-encoding genes.
    Zhang W; Li W; Li Y; Li H; Wang B; Wang F; Zhu Y; Jiang Z; Zhong L; Li M
    J Med Microbiol; 2009 Jul; 58(Pt 7):845-854. PubMed ID: 19498203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.
    Park KS; Seo YB; Lee JY; Im SJ; Seo SH; Song MS; Choi YK; Sung YC
    Vaccine; 2011 Jul; 29(33):5481-7. PubMed ID: 21664216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.
    Fotouhi F; Shaffifar M; Farahmand B; Shirian S; Saeidi M; Tabarraei A; Gorji A; Ghaemi A
    Arch Virol; 2017 May; 162(5):1251-1260. PubMed ID: 28120096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
    Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
    J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus.
    Quan FS; Huang C; Compans RW; Kang SM
    J Virol; 2007 Apr; 81(7):3514-24. PubMed ID: 17251294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
    Ryder AB; Buonocore L; Vogel L; Nachbagauer R; Krammer F; Rose JK
    J Virol; 2015 Mar; 89(5):2820-30. PubMed ID: 25540378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model.
    Shen X; Söderholm J; Lin F; Kobinger G; Bello A; Gregg DA; Broderick KE; Sardesai NY
    Vaccine; 2012 Nov; 30(48):6946-54. PubMed ID: 22406460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with hemagglutinin or neuraminidase DNA protects BALB/c mice against influenza virus infection in presence of maternal antibody.
    Chen J; Zhang F; Fang F; Chang H; Chen Z
    BMC Infect Dis; 2007 Oct; 7():118. PubMed ID: 17939857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective efficacy of a human endogenous retrovirus envelope-coated, nonreplicable, baculovirus-based hemagglutin vaccine against pandemic influenza H1N1 2009.
    Choi JY; Gwon YD; Kim JK; Cho YD; Heo YK; Cho HS; Choi TJ; Poo HR; Oh YK; Kim YB
    PLoS One; 2013; 8(11):e80762. PubMed ID: 24260476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal immunization with both hemagglutinin- and neuraminidase-expressing DNAs provides an enhanced protection against a lethal influenza virus challenge in infant and adult mice.
    Zhang F; Chen J; Fang F; Zhou Y; Wu J; Chang H; Zhang R; Wang F; Li X; Wang H; Ma G; Chen Z
    DNA Cell Biol; 2005 Nov; 24(11):758-65. PubMed ID: 16274296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation.
    Chen J; Fang F; Li X; Chang H; Chen Z
    Vaccine; 2005 Jul; 23(34):4322-8. PubMed ID: 15925433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice.
    Wang Y; Wu J; Xue C; Wu Z; Lin Y; Wei Y; Wei X; Qin J; Zhang Y; Wen Z; Chen L; Liu GD; Cao Y
    Antiviral Res; 2017 Jul; 143():97-105. PubMed ID: 28408133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection of influenza virus neuraminidase-vaccinated mice with homologous influenza virus leads to strong protection against heterologous influenza viruses.
    He B; Chang H; Liu Z; Huang C; Liu X; Zheng D; Fang F; Sun B; Chen Z
    J Gen Virol; 2014 Dec; 95(Pt 12):2627-2637. PubMed ID: 25170051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice.
    Qiu M; Fang F; Chen Y; Wang H; Chen Q; Chang H; Wang F; Wang H; Zhang R; Chen Z
    Biochem Biophys Res Commun; 2006 May; 343(4):1124-31. PubMed ID: 16580631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.